2026 ICD-10-CM Diagnosis Code C25.9Malignant neoplasm of pancreas, unspecified

ICD-10-CM CodesC00–D49C15-C26C25

ICD-10-CM C25.9
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

C25.9 is a billable ICD-10-CM diagnosis code for malignant neoplasm of pancreas, unspecified. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 435 through 437. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Endocrine system cancers - pancreas.

Code Identity

ICD-10-CM Code
C25.9
Billable Status
Yes — Valid for Submission
Code Describes
Malignant neoplasm of pancreas, unspecified
Short Description
Malignant neoplasm of pancreas, unspecified
Same as the full description in the CMS dataset.
Parent Code
Malignant neoplasm of pancreas

Code Classification

ChapterC00–D49Neoplasms
SectionC15-C26Malignant neoplasms of digestive organs
CategoryC25Malignant neoplasm of pancreas
This CodeC25.9Malignant neoplasm of pancreas, unspecified

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Acinar cell carcinoma of pancreas
  • Adenocarcinoma of pancreas
  • Adenocarcinoma of pancreas with NRG1 fusion
  • Carcinoma of pancreas
  • Cystadenocarcinoma of pancreas
  • Familial malignant neoplasm of pancreas
  • Intraductal papillary mucinous neoplasm of pancreas
  • Invasive intraductal papillary-mucinous carcinoma of pancreas
  • Local recurrence of malignant neoplasm of pancreas
  • Malignant neoplasm of exocrine pancreas
  • Malignant neoplasm of pancreas
  • Mixed neuroendocrine-non neuroendocrine neoplasm of pancreas
  • Mucinous cystadenocarcinoma of pancreas
  • Mucinous cystic neoplasm with invasive carcinoma of pancreas
  • Neoplasm of exocrine pancreas
  • Pancreatoblastoma
  • Primary acinar cell carcinoma of pancreas
  • Primary adenocarcinoma of pancreas
  • Primary carcinoma of pancreas
  • Primary cystadenocarcinoma of pancreas
  • Primary malignant neoplasm of pancreas
  • Primary malignant solid pseudopapillary neoplasm of pancreas
  • Primary mucinous cystadenocarcinoma of pancreas
  • Primary mucinous cystic neoplasm with invasive carcinoma of pancreas
  • Primary pancreatoblastoma
  • Primary sarcoma of pancreas
  • Primary sarcoma of retroperitoneum
  • Primary serous cystadenocarcinoma of pancreas
  • Primary solid pseudopapillary carcinoma of pancreas
  • Serous cystadenocarcinoma of pancreas
  • Solid pseudopapillary carcinoma of pancreas
  • Squamous cell carcinoma of exocrine pancreas
  • Tumor invades beyond pancreatic capsule to adjacent large vessels
  • Tumor invades beyond pancreatic capsule to adjacent structures AND/OR organs
  • Tumor invades beyond pancreatic capsule to bile duct
  • Tumor invades beyond pancreatic capsule to colon
  • Tumor invades beyond pancreatic capsule to duodenum
  • Tumor invades beyond pancreatic capsule to spleen
  • Tumor invades beyond pancreatic capsule to stomach
  • Tumor invades beyond pancreatic capsule, but does not invade adjacent structures AND/OR organs

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Adenocarcinoma
      • islet cell
        • with exocrine, mixed
          • unspecified site
    • Carcinoma(malignant)
      • islet cell
        • with exocrine, mixed
          • unspecified site

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR NEO051
Endocrine system cancers - pancreas
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Carcinoma, Pancreatic Ductal

    carcinoma that arises from the pancreatic ducts. it accounts for the majority of cancers derived from the pancreas.
  • Cystic Fibrosis

    an autosomal recessive genetic disease of the exocrine glands. it is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator expressed in several organs including the lung, the pancreas, the biliary system, and the sweat glands. cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in airway obstruction; chronic respiratory infections; pancreatic insufficiency; maldigestion; salt depletion; and heat prostration.
  • Insulin Infusion Systems

    portable or implantable devices for infusion of insulin. includes open-loop systems which may be patient-operated or controlled by a pre-set program and are designed for constant delivery of small quantities of insulin, increased during food ingestion, and closed-loop systems which deliver quantities of insulin automatically based on an electronic glucose sensor.
  • Islets of Langerhans

    irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the pancreas among the exocrine acini. each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. there are four major cell types. the most abundant beta cells (50-80%) secrete insulin. alpha cells (5-20%) secrete glucagon. pp cells (10-35%) secrete pancreatic polypeptide. delta cells (~5%) secrete somatostatin.
  • Nesidioblastosis

    an inherited autosomal recessive syndrome characterized by the disorganized formation of new islets in the pancreas and congenital hyperinsulinism. it is due to focal hyperplasia of pancreatic islet cells budding off from the ductal structures and forming new islets of langerhans. mutations in the islet cells involve the potassium channel gene kcnj11 or the atp-binding cassette transporter gene abcc8, both on chromosome 11.
  • Pancreas

    a nodular organ in the abdomen that contains a mixture of endocrine glands and exocrine glands. the small endocrine portion consists of the islets of langerhans secreting a number of hormones into the blood stream. the large exocrine portion (exocrine pancreas) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the duodenum.
  • Pancreas Divisum

    anatomic variants in pancreatic ducts characterized by failure of fusion of the ventral and dorsal endodermal buds. pancreas divisum results in inadequate or no communication between dorsal and ventral ducts. while most cases are asymptomatic, it may be associated with recurrent pancreatitis.
  • Pancreas Transplantation

    the transference of a pancreas from one human or animal to another.
  • Pancreas, Artificial

    devices for simulating the activity of the pancreas. they can be either electromechanical, consisting of a glucose sensor, computer, and insulin pump or bioartificial, consisting of isolated islets of langerhans in an artificial membrane.
  • Pancreas, Exocrine

    the major component (about 80%) of the pancreas composed of acinar functional units of tubular and spherical cells. the acinar cells synthesize and secrete several digestive enzymes such as trypsinogen; lipase; amylase; and ribonuclease. secretion from the exocrine pancreas drains into the pancreatic ductal system and empties into the duodenum.
  • Pancreatic Neoplasms

    tumors or cancer of the pancreas. depending on the types of islet cells present in the tumors, various hormones can be secreted: glucagon from pancreatic alpha cells; insulin from pancreatic beta cells; and somatostatin from the somatostatin-secreting cells. most are malignant except the insulin-producing tumors (insulinoma).
  • Pancrelipase

    a preparation of hog pancreatic enzymes standardized for lipase content.
  • Shwachman-Diamond Syndrome

    an inherited syndrome characterized by exocrine pancreatic insufficiency; hematologic abnormalities (e.g., bone marrow hypoplasia), and skeletal abnormalities (e.g., metaphyseal chondroplasia). germline mutations in the sbds gene are associated with shwachman-diamond syndrome.
  • Childhood Pancreatoblastoma|Pediatric Pancreatoblastoma

    a pancreatoblastoma that occurs during childhood. it is the most common malignant pancreatic neoplasm in children younger than ten years of age.
  • Pancreatoblastoma

    a rare malignant epithelial neoplasm arising from the pancreas. the vast majority of cases occur during childhood. it is characterized by acinar differentiation, the formation of squamoid corpuscles, and the formation of stromal bands. patients may present with an abdominal mass. symptoms include pain, weight loss, and diarrhea. it may metastasize to lymph nodes, liver, and distant anatomic sites. children who do not have metastatic disease at the time of diagnosis usually have a favorable clinical outcome when treated with a combination of surgery and chemotherapy. however, children with metastatic disease at presentation or adult patients usually have a poor prognosis.

Table of NeoplasmsClinical

Anatomical sites in the Table of Neoplasms that reference this code family.

SiteMalig.
Primary
Malig.
Secondary
Ca
in situ
BenignUncertainUnspec.
pancreasC25.9C78.89D01.7D13.6D37.8D49.0

Patient EducationClinical

Pancreatic Cancer

The pancreas is a gland behind your stomach and in front of your spine. It produces the juices that help break down food and the hormones that help control blood sugar levels. Pancreatic cancer usually begins in the cells that produce the juices. Some risk factors for developing pancreatic cancer include:

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert C25.9 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
157.9 Malig neo pancreas NOS
Exact Match The mapping is direct, with no qualifiers.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About C25.9Overview

Is C25.9 (Malignant neoplasm of pancreas) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report malignant neoplasm of pancreas, unspecified on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does C25.9 group to?

When malignant neoplasm of pancreas, unspecified is the principal diagnosis on an inpatient stay, it groups to MS-DRG 435, 436, 437, with relative weights from 0.8533 to 1.8367 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of C25.9?

Under the General Equivalence Mappings, malignant neoplasm of pancreas, unspecified converts to ICD-9-CM 157.9 (malig neo pancreas NOS). The mapping is a direct match.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.